Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture

ClinicalTrials.gov ID: NCT02719769

Public ClinicalTrials.gov record NCT02719769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The "Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification \& Antimicrobial Susceptibility Testing" is designed to validate the clinical performance of the Accelerate ID/AST System for positive blood culture identification and susceptibility testing in a clinical setting. The data from this study will be used to support the 510(k) submission for FDA clearance and global registrations of the device intended for in vitro diagnostic use.

Study identification

NCT ID
NCT02719769
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Accelerate Diagnostics, Inc.
Industry
Enrollment
4,009 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2016 (Actual)
Primary completion
May 2016 (Actual)
Completion
Jan 12, 2017 (Actual)
Last update posted
Sep 27, 2017

2016 – 2017

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Banner Health- Laboratory Sciences of Arizona Gilbert Arizona 85234 —
Accelerate Diagnostics Inc. Tucson Arizona 85714 —
UCLA Medical Center Los Angeles California 90046 —
Cedars Sinai Medical Center Los Angeles California 90048 —
MRI Global Palm Bay Florida 32909-2211 —
Loyola University Medical Center Maywood Illinois 60153 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242-1396 —
Johns Hopkins University School of Medicine Baltimore Maryland 21287 —
Mayo Clinic Rochester Minnesota 55905 —
Lab Alliance of Central New York LLC Liverpool New York 13088 —
The Ohio State University Columbus Ohio 43205 —
Geisinger Clinic Danville Pennsylvania 17822 —
med fusion LLC Lewisville Texas 75067 —
Medical College of Wisconsin Milwaukee Wisconsin 53276 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02719769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2017 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02719769 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →